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Proliferating cell nuclear antigen (PCNA) plays a critical role as a processivity clamp for eukaryotic 
DNA polymerases and a binding platform for many DNA replication and repair proteins. The enzymatic 
activities of PCNA loading and unloading have been studied extensively in vitro. However, the 
subcellular locations of PCNA loaders, replication complex C (RFC) and CTF18‑RFC‑like‑complex (RLC), 
and PCNA unloader ATAD5‑RLC remain elusive, and the role of their subunits RFC2‑5 is unknown. Here 
we used protein fractionation to determine the subcellular localization of RFC and RLCs and affinity 
purification to find molecular requirements for the newly defined location. All RFC/RLC proteins were 
detected in the nuclease‑resistant pellet fraction. RFC1 and ATAD5 were not detected in the non‑
ionic detergent‑soluble and nuclease‑susceptible chromatin fractions, independent of cell cycle or 
exogenous DNA damage. We found that small RFC proteins contribute to maintaining protein levels 
of the RFC/RLCs. RFC1, ATAD5, and RFC4 co‑immunoprecipitated with lamina‑associated polypeptide 
2 (LAP2) α which regulates intranuclear lamin A/C. LAP2α knockout consistently reduced detection of 
RFC/RLCs in the pellet fraction, while marginally affecting total protein levels. Our findings strongly 
suggest that PCNA‑mediated DNA transaction occurs through regulatory machinery associated with 
nuclear structures, such as the nuclear matrix.
The nuclear lamina, located just beneath the inner nuclear membrane (INM), is composed of A- or B-type lamins 
and their many lamina-associated  proteins1,2. The A-type lamins (lamin A and C, lamin A/C) and B-type lamins, 
in a complex with lamina-associated polypeptide (LAP)-Emerin-MAN1 (LEM) domain proteins and lamin B 
receptor of the INM, respectively, tether heterochromatic genomic regions to the nuclear  periphery3. These 
structures shape the spatial architecture of chromatin, which is closely related to gene regulation and replication 
timing in the interphase  nucleus1,4,5.
Unlike B-type lamins, which are primarily present in the nuclear lamina, about 10% of lamin A/C are also 
found in the  nucleoplasm6,7. In the nucleoplasm, lamin A/C binds to euchromatin, which is regulated by asso-
ciation with the nucleoplasmic LEM domain protein LAP2α1. Nucleoplasmic lamin A/C limits free diffusion of 
fluorescently tagged genomic regions but depletion of LAP2α does not affect chromatin  diffusion8. However, 
another recent report showed that depletion of LAP2α reduces the mobility of nucleoplasmic lamin A/C, which 
in turn reduces chromatin  diffusion9. This suggests that nucleoplasmic lamins, like the peripheral lamina, con-
tribute to chromatin architecture. However, it is still not clear whether internal lamins also provide structural 
platforms for specific functions, such as gene regulation and DNA replication and repair.
During the S phase in eukaryotic cells, the entire genome is replicated in units of replication  domains5,10. 
Labeling of replicating DNA with nucleotide analog bromodeoxyuridne (BrdU) shows a distinctive focal pat-
tern where each focus represents an active replication  domain11,12. In early S phase, foci appear throughout the 
entire nucleoplasm, whereas foci in mid- and late S phase appear only in the nuclear periphery and outside the 
nucleoli. In a single replication domain, three to five out of many licensed origins fire simultaneously and initiate 
replication at a specific location called the replication  factory13. In the replication factory, replication proteins 
associated with replication forks from the origin firing and timely recruited to replication forks, participate in 
DNA synthesis, Okazaki fragment maturation, sister chromatid cohesion, DNA repair, and checkpoint activation.
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Proliferating cell nuclear antigen (PCNA), the eukaryotic sliding clamp, plays a critical role as a processivity 
factor for replicative DNA polymerases and as a binding platform for many proteins involved in different DNA 
 transactions14. The replication factor C (RFC) complex, a pentameric AAA + ATPase complex composed of a large 
subunit, RFC1, and four small RFC proteins, RFC2, 3, 4, and  515,16, loads PCNA onto DNA at the double-strand/
single-strand DNA junction with the 3′-hydroxyl group. Eukaryotes have three RFC-like complexes (RLCs), 
which have overlapping, as well as distinct, cellular tasks. Each RLC complex is composed of one of three large 
subunits: CTF18, ATAD5 (Elg1 in yeast), or RAD17 (Rad24 in budding yeast) and four small subunits of RFC2-
517. The CTF18-RLC complex loads PCNA in a manner similar to the RFC complex, but unlike RFC-loaded 
PCNA, CTF18-RLC-loaded PCNA participates in cohesion establishment and checkpoint  activation18. After 
DNA synthesis is complete, ATAD5-RLC unloads PCNA from  DNA19–21. RAD17-RLC loads another ring-shaped 
clamp, RAD9-RAD1-HUS1 (the 9-1-1 complex, Ddc1-Rad17‐Mec3, in budding yeast)22, which plays a role in 
checkpoint  activation23,24.
Previous reports show that replication along each replication domain occurs in a spatially stationary or 
minimally mobile fashion in living  cells25,26. Several elements support this stationary replication. Chromatin-
intrinsic features help maintain stationary replication at the level of the replication domain. About 40% of the 
genome is bound to the lamina through lamina-associated domains on  chromatin27. In addition, chromatin is 
self-organized in a megabase-sized topologically associating domain (TAD)28,29. Each TAD serves as a structural 
platform for contacts between promoters and enhancers, and at least one TAD may correspond to a replication 
 domain30,31. It has been suggested that adjacent TADs are linked by interaction between genome-dispersed 
repetitive  sequences31. Associations of chromatin with lamina and interactions between TADs stabilize chromatin 
architecture, which can contribute to the relatively stationary replication.
Replication machineries may also be tethered to immobile support in the nuclear interior, further contributing 
to stationary  replication32. PCNA and lamin A/C directly interact, and replicative DNA polymerases associate 
with lamin A/C33–35. In addition, a study in budding yeast shows that DNA is replicated by passing through a 
stationary replication  factory36. Due to the multiple essential roles of PCNA in cellular processes, PCNA loading 
and unloading needs to be accurately regulated. However, it has not been investigated how the PCNA loading 
and unloading complexes perform their tasks within the chromatin architecture and whether they are tethered 
to a mechanical support for stationary replication. To answer these questions, we analyzed the structural localiza-
tion of RFC/RLCs and other replication-related proteins. We discovered that all RFC/RLC proteins were found 
in nuclease-resistant protein fractions; this localization was not affected by cell cycle or DNA damage. We also 
identified the protein–protein interaction between the RFC/RLC proteins and LAP2 proteins and found reduced 
association of RFC/RLC proteins with nuclease-resistant structures in mouse Lap2α knockout cells.
Results
RFC/RLC proteins are present in nuclease‑ and high salt‑resistant protein fractions. To inves-
tigate the structural localization of RFC/RLCs and other replication-related proteins, we sequentially extracted 
proteins from asynchronous human HeLa and HEK293T cells (Fig. 1A). We chose a nonionic detergent-based 
extraction method to preserve protein–protein interactions during subcellular  fractionation37. First, we isolated 
cytoplasmic and nucleoplasmic proteins using cytoskeleton (CSK) buffer (soluble fraction). Next, we isolated 
nuclease-susceptible chromatin-associated proteins by digesting the pellet with nuclease (chromatin fraction). 
After washing the pellet with 2 M NaCl, we solubilized nuclease- and high salt-resistant nuclear matrix (NM) 
proteins and proteins associated with the NM or nuclease-resistant chromatin (pellet fraction). We confirmed 
the feasibility of the fractionation procedure by the detection of α-tubulin, histone H3, and lamin proteins in the 
expected fraction, respectively (Fig. 1B and Supplementary Fig. 1).
We next examined the fractionation profile of the RFC/RLC proteins (Fig. 1C and Supplementary Fig. 1). 
As expected, we detected PCNA in both soluble and chromatin fractions. Conversely, RFC/RLC proteins were 
present in the soluble and pellet fractions but not in the chromatin fraction. In particular, RFC1 and ATAD5 
were detected only in the pellet fraction. Considering the roles of the RFC and ATAD5-RLC in PCNA loading/
unloading, this profile was unexpected. Therefore, we tested the possibility that this profile was a result of our 
fractionation procedure. First, we examined the effects of ammonium sulfate, which is commonly used to pre-
cipitate proteins in various purification  assays38. We considered the possibility that the 3% ammonium sulfate 
solution used to elute chromatin, as well as chromatin-associated proteins such as PCNA and RPA2 (Fig. 1D), 
could unintentionally precipitate RFC/RLC proteins as well. However, even when we omitted the ammonium 
sulfate step from the fractionation procedure, we did not detect RFC/RLC proteins in the soluble and chromatin 
fractions (Fig. 1D).
It is also possible that RFC1 and ATAD5 proteins are intrinsically unstable and form aggregates during the 
fractionation procedure, leading to detection only in the pellet. When we overexpressed Strep-tag II-FLAG-
tagged RFC1 and 3xFLAG-tagged ATAD5 in the cells, we did detect both proteins in the soluble and chromatin 
fractions, albeit at much lower levels than in the pellet fraction (Fig. 1E,F). In addition, when we used Radio-
immunoprecipitation assay (RIPA) buffer containing the ionic detergents sodium dodecyl sulfate and sodium 
deoxycholate, which potentially denature proteins or disrupt protein–protein interaction, a significant amount of 
RFC1 was solubilized and nearly all CTF18 and RAD17 proteins were detected in the RIPA-soluble fraction with-
out nuclease treatment or sonication (Fig. 1G). However, ATAD5 was still detected only in the RIPA-insoluble 
pellet with a portion of small RFC proteins (Fig. 1G). ATAD5 was partly solubilized in the RIPA buffer and much 
milder buffer X upon nuclease treatment followed by  sonication39. Accordingly, when we added the sonication 
step after nuclease treatment, we detected only small amounts of RFC1 and ATAD5 in the chromatin fraction, 
while most RFC1 and ATAD5 remained in the pellet fraction (Fig. 1G). These results minimize the possibility 
that RFC/RLC proteins are inherently vulnerable to our fractionation procedure and suggest that ATAD5-RLC 
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Figure 1.  RFC/RLC proteins are present in nuclease- and high salt-resistant protein fraction. (A) The scheme for protein 
fractionation method. Detailed procedure was described in the method section. (B–F, J) HeLa cells were fractionated as 
the scheme in (A). Soluble (Sol), chromatin (Ch) and pellet (Pe) fractions were subjected to immunoblotting as indicated. 
(D) Chromatin and pellet fractions were prepared with or without ammonium sulfate (AS) step (−). (E, F) HeLa cells were 
transfected with Strep-tag II-FLAG-tagged RFC1 (SII-F-RFC1) (E) or 3xFLAG-tagged ATAD5 (FLAG-ATAD5) cDNA 
48 h before protein fractionation. (G) (left two lanes) HeLa cells were lysed with RIPA buffer without Benzonase nuclease 
treatment, and soluble (S) and pellet (P) proteins were subjected to immunoblotting. (right three lanes) HeLa cells were 
fractionated as the scheme in (A) but sonication step was added after Benzonase nuclease treatment. (H, I) HeLa cells 
were transfected with mNeonGreen-tagged RFC1 (H) or mNeonGreen-tagged ATAD5 (I) cDNA. Forty-eight hours after 
transfection, cells were fixed or pre-treated with CSK alone or CSK plus Benzonase with the same condition as in (A) and then 
fixed for immunostaining. Scale bar = 5 μm. (B–G, J) Uncropped blot images are presented in Supplementary Fig. 5.
4
Vol:.(1234567890)
Scientific Reports |        (2021) 11:21817  | https://doi.org/10.1038/s41598-021-01336-w
www.nature.com/scientificreports/
proteins are more resistant to harsh extraction techniques compared to other RFC/RLC proteins. Finally, when 
we expressed mNeonGreen fluorescence protein-tagged RFC1 or ATAD5 in cells, we detected the mNeonGreen 
signal in the nucleus even after extracting soluble and chromatin-associated proteins using CSK and nuclease 
treatment as exemplified by the step-wise disappearance of PCNA signals (Fig. 1H,I). Interestingly, most of the 
mNeonGreen-RFC1 and mNeonGreen-ATAD5 signals overlapped with the DAPI signals remained after CSK 
and nuclease treatment. Collectively, our data suggest that a majority of RFC and ATAD5-RLC proteins are 
associated with the chromatin or NM inaccessible to exogenous nucleases.
We next examined the fractionation profile of several replication-related proteins. Origin licensing occurs 
during early G1 phase, beginning with origin recognition by the origin recognition complex and followed by 
chromatin licensing and DNA replication factor 1 (CDT1)-mediated minichromosome maintenance (MCM) 
helicase  loading40,41. CDT1 was primarily detected in the soluble and pellet fractions, while MCM helicase subunit 
MCM2 was detected predominantly in the chromatin fraction and less abundantly in the pellet fraction (Fig. 1J 
and Supplementary Fig. 1). The phosphorylation of MCM2 at serine 40 and 41 residues, mediated by cell divi-
sion cycle 7 (CDC7) kinase and cyclin-dependent kinase 2 (CDK2), respectively, is associated with replication 
 initiation42. MCM2 phosphorylation at serine 40 or 41 was not detected in the pellet fraction (Fig. 1J). This result 
is in line with a previous report that showed that MCM2 is tightly associated with chromatin but not with the 
NM upon replication  initiation43. Replication protein A 2 (RPA2), a single-stranded DNA binding protein, and 
PCNA-interacting flap endonuclease 1 (FEN1), an Okazaki fragment processing enzyme, had a fractionation 
profile similar to that of PCNA (Fig. 1J and Supplementary Fig. 1). However, DNA polymerase δ, a replicative 
polymerase for the lagging strand which also interacts with PCNA, was detected more highly in the pellet than 
in the chromatin fraction. These results suggest that replication-related proteins that commonly require PCNA 
binding perform their tasks with a different subcellular localization profile.
The fractionation profile of RFC/RLC proteins is maintained throughout cell cycle with distinct 
mitotic phosphorylation of large subunits. PCNA loading and unloading primarily occurs during 
S-phase DNA replication. Therefore, it is expected that a portion of RFC, CTF18-RLC, and ATAD5-RLC would 
be associated with chromatin during PCNA loading and unloading during S phase. However, since RFC1 and 
ATAD5 were detected only in the pellet and not in the chromatin fraction (Fig. 1C), we examined whether the 
fractionation profile of RFC/RLC proteins changed at specific cell cycle stages. We synchronized cells at the 
mitotic phase using the thymidine and nocodazole block method and released them from the arrest to enrich for 
cells at specific cell cycle phases for protein fractionation (Fig. 2A). As expected, we detected PCNA in the chro-
matin fraction only in S phase. However, RFC and RLC proteins did not change the fractionation profile by cell 
cycle stages. In particular, RFC1 and ATAD5 were detected only in the pellet fraction throughout the cell cycle. 
In cells arrested at prophase/prometaphase by nocodazole treatment, lamina disassembly and nuclear envelope 
breakdown are  inhibited44, which might explain the presence of RFC/RLCs in the pellet fraction.
Notably, all large subunits of the RFC/RLCs displayed slightly up-shifted bands in the mitotic phase (Fig. 2A). 
The band shift disappeared after we treated the protein sample with phosphatase (Fig. 2B), indicating that all large 
subunits of the RFC and RLCs undergo phosphorylation during mitosis. This result is consistent with previous 
proteomics studies which show that several residues on RFC1, ATAD5, and CTF18 are highly phosphorylated in 
cells arrested at the G2/M phases compared to asynchronous  cells45,46. Among the phosphorylation sites, serine 
281 of RFC1 and serine 369 of ATAD5 are present in the consensus phosphorylation motif for aurora A kinase 
(AURKA) and aurora B kinase (AURKB), which are master mitotic  kinases47.
We decided to investigate the serine 369 (pS369) phosphorylation site of ATAD5 further. We generated anti-
pS369 ATAD5 antibody and then performed an in vitro aurora kinase assay with the purified ATAD5 fragment 
(residues 1–400) (Fig. 2C,D). We detected pS369-ATAD5 in reactions with wild-type (WT) ATAD5 and purified 
AURKA but not in reactions with kinase-dead AURKA or with the ATAD5 S369 to alanine (SA) substitution 
mutant (Fig. 2C). pS369-ATAD5 was also detected in reactions with purified AURKB but not in reactions with 
the ATAD5 SA mutant (Fig. 2D). In addition, pS369-ATAD5 disappeared when inhibitors for AURKA and 
AURKB, alisertib and barasertib, respectively, were included in the kinase reactions (Fig. 2C,D). These results 
suggest that ATAD5 is phosphorylated by either AURKA or AURKB.
Next, we examined the phosphorylation of ATAD5 at S369 in cells during mitosis. Phosphorylation of endog-
enous ATAD5 at S369 was observed in cells arrested at the G2/M phase by nocodazole treatment (Fig. 2E). 
When cells were released from G2 arrest by treatment of the CDK1 inhibitor RO-3306, they entered mitosis 
within 30 min as determined by mitosis marker pS10-histone H3 (Fig. 2F). Accordingly, pS369-ATAD5 intensity 
reached its maximum 30 min after release, gradually decreased, and then disappeared simultaneously with the 
pS10-histone H3 signal, suggesting that ATAD5 is phosphorylated at S369 in cells during mitosis. Mitotic phos-
phorylation of FLAG-tagged and endogenous ATAD5 at S369 was reduced by small interfering RNA (siRNA)-
mediated depletion of AURKA or AURKB (Fig. 2G,H). Treatment with alisertib or barasertib alone slightly 
reduced pS369-ATAD5, and co-treatment with both drugs significantly reduced pS369-ATAD5 (Fig. 2I). These 
data suggest that ATAD5 at S369 is phosphorylated by two aurora kinases during mitosis. Lastly, we found that 
both the phosphorylation-defective ATAD5 S369A and the phosphomimetic S369E (S369 to glutamate) mutant 
proteins displayed a fractionation profile similar to that of wild-type ATAD5 (Supplementary Fig. 2), suggesting 
that the phosphorylation of ATAD5 at S369 is not required for association of ATAD5 with nuclease-resistant 
structures during mitosis.
The fractionation profile of RFC/RLC proteins is not changed by DNA damage. Besides DNA 
replication during S phase, DNA synthesis also occurs during the DNA repair process, including base or nucleo-
tide excision repair and homologous recombination of double-strand breaks (DSBs), which accompany PCNA 
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Figure 2.  The fractionation profile of RFC/RLC proteins is maintained throughout cell cycle. (A) HeLa 
cells were arrested at the mitotic (M) phase using thymidine-nocodazole block and the shaked-off cells were 
re-seeded in fresh media and incubated for 4 h (G1) and 12 h (S). Cells at each phase and asynchronous (As) 
cells were collected, fractionated and subjected to immunoblotting. (B) HeLa cells asynchronous or arrested at 
the mitotic phase by treatment of nocodazole (Noco) were fractionated. Lambda phosphatase (λ-PP) (400 Unit/
sample) was added during the nuclease treatment step and pellet (Pe) fraction was subjected to immunoblotting. 
(C, D) The in vitro kinase assay. The purified wild-type (WT) or S369A (SA) mutant of ATAD5 fragment 
(residues 1–400) was incubated with the recombinant wild-type (+) or kinase-dead (KD) AURKA (C) or 
AURKB (D) for indicated times. Alisertib (C) or Barasertib (D) was added in the reaction as indicated. The 
reaction samples were subjected to immunoblotting. (D) ATAD5 was detected by Ponceau S (Ponc.) staining. 
(E) Whole-cell extracts were prepared from HEK293T cells asynchronous (Asy) or arrested at the mitotic phase 
by treatment of nocodazole, and then subjected to immunoprecipitation with anti-ATAD5 antibody. Lambda 
phosphatase (λ-PP) (400 Unit/sample) was added during the nuclease treatment step. (F) HEK293T cells were 
transfected with 3xFLAG-tagged ATAD5 fragment (residues 1–400) cDNA. One day after, cells were arrested 
at the G2 phase by treatment of RO-3306 (RO) for 16 h and released from the arrest during the indicated time. 
Whole-cell extracts were prepared for immunoprecipitation with anti-FLAG antibody. (G–I) HEK293T cells 
were transfected with a combination of 3xFLAG-tagged ATAD5 cDNA and AURK siRNAs (G), AURK siRNAs 
(H), or 3xFLAG-tagged ATAD5 cDNA (I) as indicated. After transfection, cells were arrested at the mitotic 
phase by treatment of nocodazole. (I) Cells were treated with kinase inhibitors. Then whole-cell extracts were 
prepared for immunoprecipitation with anti-ATAD5 (H) or anti-FLAG antibody (G, I). (A–I) Uncropped blot 
images are presented in Supplementary Fig. 5.
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loading and unloading by RFC and ATAD5-RLC,  respectively17. RFC and ATAD5 rapidly move to ultraviolet 
laser-generated DNA  lesions48,49. In budding yeast, Elg1 and Ctf18 move to DSB  sites50,51. RAD17-RLC loads the 
9-1-1 complex at DNA damage sites for checkpoint  activation23,24.
Based on the involvement of RFC and three RLCs in the DNA damage repair pathway, we investigated 
whether the fractionation profile of RFC/RLC is affected by DNA damage using HeLa and HEK293T cells. We 
applied three different types of DNA damage: ionizing radiation (IR), camptothecin (CPT), and methyl methane-
sulfonate (MMS). The repair mechanisms for these types of damage, including homologous recombination, base 
excision repair (BER), and single-strand break repair (SSBR), each utilize DNA synthesis. None of the three types 
of DNA damage led to detection of RFC/RLC proteins in the chromatin fraction, and the overall fractionation 
profile remained the same in both cells (Fig. 3A–D). Treatment with CPT or MMS slightly reduced the amount 
of RFC1 and ATAD5 protein in the pellet fraction in HeLa but not in HEK293T cells (Fig. 3C,D). The most 
prominent change was the increase of RAD17 in the pellet fraction following MMS treatment (Fig. 3C), which 
is likely related to damage checkpoint activation. A recent report found that TopBP1 forms micrometer-sized 
condensates at DNA replication impediments and switches on ATR checkpoint  signaling52. Considering the 
cooperative role of the RAD17-RLC-loaded 9-1-1 clamp with TopBP1 in checkpoint  activation23,24, it is possible 
that the increased RAD17 in the pellet fraction co-exists with TopBP1 condensates.
RFC4 and RFC5 are important for the protein stability of RFC/RLCs. The RFC and three RLCs 
share small RFC subunits. Because all large subunits of the RFC/RLCs were detected in the pellet fraction and 
RFC4 bridges a large subunit to other small subunits in the RFC/RLCs16, we checked the effects of RFC4 deple-
tion on the fractionation profile in HeLa and HEK293T cells. We found that RFC4 depletion reduced the level 
of all other RFC/RLC proteins, both in the soluble and pellet fractions (Fig. 4A and Supplementary Fig. 3A). 
Depletion of RFC5 also displayed a similar but less pronounced effect on other RFC/RLC proteins (Fig. 4B). This 
suggests that the protein levels of other subunits of RFC/RLC proteins are affected by the depletion of any small 
RFC subunit. When we checked the protein levels in whole cell extracts, depletion of RFC4 or RFC5 consistently 
reduced the protein amount of other RFC/RLC subunit proteins in both cell lines (Fig. 4C and Supplementary 
Fig. 3B). To check whether the reduction results from proteasomal degradation, we used a proteasome inhibitor 
and monitored protein levels of RFC/RLC subunits. Slight increase of total protein levels of RFC1 and ATAD5 
by treatment of MG132 suggest that two proteins are regulated by proteasomal degradation pathway in unper-
turbed cells (Fig. 4D). However, the treatment did not restore total protein levels of RFC/RLC proteins reduced 
by RFC4 depletion (Fig. 4D). These results suggest that the reduction of RFC/RLC subunit proteins upon RFC4 
depletion is due to destabilization of the RFC/RLCs rather than through active degradation mechanisms.
Because the small RFC subunits affected the protein amount of the large subunits, we investigated whether 
interaction between small and large subunits—in particular, the ATAD5—affects the fractionation profile of 
the large subunit. The large subunit ATAD5 directly interacts with a subset of proteins, including ubiquitin 
specific protease 1-associated factor (UAF1), chromatin reader bromodomain-containing protein 4 (BRD4), 
and recombinase RAD51, via the N-terminal region (residues 368–693)39,53–55. The C-terminal region of ATAD5 
contains the ATPase domain (residues 1052–1412) and the small RFC interacting domain (residues 1602–1844). 
The ATAD5 C-terminal fragments (residues 694–1844) can unload PCNA both in vitro and in  cells19. We exam-
ined the fractionation profile of the ATAD5 N-terminal fragment (residues 1–693, N), C-terminal fragment 
(residues 694–1844, C), and C-terminal fragment with a defect in the portion that interacts with the small RFC 
subunit (residues 694–1719, C∆). Even with slightly higher protein expression than the C-terminal fragment 
(Fig. 4F), the N-terminal fragment was still predominantly detected in the pellet fraction (Fig. 4E). Although 
both C-terminal fragments (C and C∆) were detected in the soluble and pellet fractions, protein levels of the C∆ 
fragment were much lower in the pellet fraction compared to the C-terminal fragment (Fig. 4E). These results 
suggest that, in the case of ATAD5, both N-terminal and C-terminal regions have the capacity to associate with 
the NM or chromatin inaccessible to nucleases, and the interaction with small RFC subunits contributes to, but 
is not required for, this association. Since the N-terminal fragment of ATAD5 was found in the pellet fraction, 
we examined the contribution of two ATAD5 interacting proteins, UAF1 and BRD4, to the retention of ATAD5 
in the nuclease-resistant structures. Depletion of UAF1 or BRD4 did not change the fractionation profile of 
ATAD5 (Fig. 4G,H). These results suggest that there are other mechanisms to maintain association of the ATAD5 
N-terminal fragment with nuclease-resistant structures.
LAP2 interacts with ATAD5, RFC1 and RFC4. To find the molecular requirements for the association 
of RFC/RLCs with nuclease-resistant structures, we identified proteins that interact with the RFC/RLC proteins. 
We conducted affinity purification-mass spectrometry analysis using the immunoprecipitates of Strep-tag II 
tagged-ATAD5 expressed in  cells56. The analysis revealed the thymopoietin (TMPO) gene product as the puta-
tive ATAD5 interacting protein (Fig. 5A). Two major TMPO gene products are LAP2α and β57–59. LAP2α is 
present in the nucleoplasm and is associated with intra-nuclear lamin A/C. LAP2β is a transmembrane protein 
that is incorporated into the nuclear inner membrane and the nuclear laminar structure and is thought to be 
important for chromatin association with the lamina.
We first confirmed the protein–protein interactions between ATAD5 and LAP2α and β. Immunoprecipitation 
of FLAG-ATAD5 pulled down HA-LAP2α and HA-LAP2β (Fig. 5B,C). Immunoprecipitation of HA-LAP2α also 
pulled down FLAG-ATAD5 (Fig. 5D). In addition, immunoprecipitation of either HA-LAP2α or HA-LAP2β 
pulled down RFC1 in cells transiently overexpressing RFC1 (Fig. 5E). Because RFC and ATAD5-RLC share the 
small RFC subunits, we also checked protein–protein interactions between RFC4 and LAP2. Immunoprecipita-
tion of either HA-LAP2α or HA-LAP2β pulled down RFC4 in cells transiently overexpressing RFC4, and immu-
noprecipitation of FLAG-RFC4 pulled down HA-LAP2α and HA-LAP2β (Fig. 5F–H). Based on the association 
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of LAP2 proteins with the NM, these results suggest that LAP2α and β may contribute to the association of RFC 
and ATAD5-RLC with the NM. We tried to detect interactions between endogenous LAP2α and ATAD5, RFC1 















































































































































Figure 3.  The fractionation profile of RFC/RLC proteins is not affected by DNA damage. (A, B) HeLa (A) or 
HEK293T (B) cells were irradiated with 10 Gy (Gy) X-ray and recovered for indicated times. (C, D) HeLa (C) 
or HEK293T (D) cells were treated 2 μM camptothecin (CPT) or 0.02% methyl methanesulfonate (MMS) for 
2 h. (A–D) After treatment, cells were fractionated and each fraction was subjected to immunoblotting. (A–D) 
Uncropped blot images are presented in Supplementary Fig. 5.
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Figure 4.  RFC4 and RFC5 maintain the protein levels of RFC/RLC proteins. (A–D) HeLa cells were transfected 
with siRNA as indicated. Forty-eight hours after transfection, cells were fractionated (A, B) or whole-cell 
extracts was prepared (C, D) for immunoblotting. (D) 10 μM MG132 was treated for 5 h before cell harvest. (E, 
F) HeLa cells were transfected with 3xFLAG-tagged full length ATAD5 (FL), N-terminal fragment (residues 
1–693, N), C-terminal fragment (residues 694–1844, C) or small RFC interaction-defective C-terminal fragment 
(residues 694–1719, C∆) cDNA. Forty-eight hours after transfection, cells were fractionated (E) or whole-cell 
extracts were prepared (F), and then proteins were subjected to immunoblotting. (E) *, nonspecific band. (G, H) 
HeLa cells were transfected with siRNA as indicated and fractionated for immunoblotting. (A–H) Uncropped 
blot images are presented in Supplementary Fig. 5.
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Figure 5.  LAP2 interacts with the ATAD5, RFC1 and RFC4. (A) HEK293T cells were transfected with control 
Strep-tag II vector (vector) or Strep-tag II-tagged ATAD5 (Strep-ATAD5) cDNA. Forty-eight hours after 
transfection, proteins were extracted and subjected to affinity purification-mass spectrometry analysis. The 
numbers of peptide hits for some selected proteins from the analysis were displayed. Protein in red indicate 
TMPO gene products. (B, C, D) HEK293T cells were co-transfected with 3xFLAG-tagged ATAD5 and 
HA-tagged LAP2α (B, C) or LAP2β (D) cDNA. Whole-cell extracts were immunoprecipitated with anti-FLAG 
(B, D) or anti-HA (C) antibody followed by immunoblotting. (E, F) HEK293T cells were co-transfected with 
HA-tagged LAP2α or LAP2β and RFC1 or RFC4 cDNA. Whole-cell extracts were immunoprecipitated with 
anti-HA antibody followed by immunoblotting. (G, H) HEK293T cells were co-transfected with HA-tagged 
LAP2α or LAP2β and 3xFLAG-tagged RFC4 cDNA. Whole-cell extracts were immunoprecipitated with anti-
FLAG antibody followed by immunoblotting. (I) HEK293T cells were transfected with HA-tagged LAP2α 
cDNA. Whole-cell extracts were immunoprecipitated with anti-HA antibody followed by immunoblotting. 
(B–I) Uncropped blot images are presented in Supplementary Fig. 5.
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down endogenous RFC4 (Fig. 5I). Even in this trial, we could not detect ATAD5 or RFC1. We speculate that the 
interactions are not strong or very small fractions of protein interact with each other.
LAP2α deficiency reduces the association of RFC/RLC proteins with nuclease‑resistant struc‑
tures. We examined the effects of LAP2α depletion on the fractionation profile of RFC/RLCs using Lap2α 
knockout mouse dermal fibroblast  cells60. We found that the protein levels of all RFC/RLC proteins in the pellet 
fraction were reduced in the Lap2α knockout cells (Fig. 6A). LAP2α deficiency reduced the protein levels of most 
RFC/RLC proteins in the soluble fraction, similar to RFC4 depletion, but the reduced amount was lower com-
pared to RFC4 depletion. In the RFC4-depleted cells (Fig. 4A), the degree of reduction of RFC/RLC proteins was 
larger in the soluble fraction than in the pellet fraction. However, in Lap2α knockout cells (Fig. 6A), the degree 
of reduction of RFC/RLC proteins was milder in the soluble fraction than the pellet fraction. Consistently, the 
effects of LAP2α depletion on total protein level of the RFC/RLC proteins was low and variable compared to the 
pleiotropic effects of RFC4 depletion (Fig. 6B). Only RFC1 and CTF18 showed a marked reduction in the Lap2α 
knockout cells, while other RFC/RLC proteins decreased only marginally (Fig. 6B). These results suggest that 
the association of the RFC/RLC proteins with the nuclease-resistant structures is reduced in the Lap2α knockout 
cells.
We also examined the effects of LAP2α depletion on the fractionation profile of RFC/RLCs in HeLa cells. We 
could not see any differences in the fractionation profiles of the RFC/RLC proteins by one-time LAP2ɑ siRNA 
transfection. When LAP2ɑ was depleted for a longer time, a clear reduction in the pellet fraction and total 
protein level of RFC1 was observed (Supplementary Fig. 4A,B). While slight reduction of ATAD5 and CTF18 in 
the pellet fraction was also observed in the LAP2ɑ-depleted cells, the fractionation profiles of other RFC/RLC 
proteins were not significantly changed. It cannot be excluded that the reduction in RFC1 in LAP2ɑ-depleted 
HeLa cells results from alteration in nuclear matrix as observed by reduction of Lamin B1 in the pellet frac-
tion and whole cell extracts although the fractionation profiles of another nuclear matrix protein, Emerin was 
not changed. Overall, the effect of LAP2ɑ depletion by siRNA in HeLa cells was marginal compared to Lap2α 
knockout mouse fibroblast cells.
Discussion
In this report, we performed subcellular fractionation to identify structural localization of RFC/RLC and other 
replication-related proteins. Unexpectedly, we detected RFC1 and ATAD5 only in the nuclease- and high salt-
resistant fraction, while small RFC proteins were located in both soluble and pellet fractions (Fig. 1C and 
Supplementary Fig. 1), which were independent of cell cycle and DNA damage (Figs. 2, 3). PCNA performs its 
role as a processivity factor and as a binding platform while encircling chromatin  DNA14. PCNA loading and 
unloading is closely associated with chromatin during DNA replication and repair. It has been assumed that 
the RFC and ATAD5-RLC might be recruited in a timely manner from the nucleoplasmic pool to replication 
forks or damaged sites or that they are at least associated with chromatin at the time of their action. However, 
neither RFC1 nor ATAD5 were detected in the soluble or chromatin fractions in our fractionation procedure, 
which employed the widely used CSK extraction and nuclease treatment (Fig. 1C and Supplementary Fig. 1). 
We tested the possibility that these results were artifactual by modifying our extraction procedure and checking 
the fractionation profile of exogenously expressed RFC1 and ATAD5. After carefully minimizing the possibility 
of experimental artifacts using different fractionation methods, we strongly believe that most RFC and ATAD5-
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Figure 6.  The association of RFC/RLC proteins with nuclease-resistant structures is reduced in Lap2α knockout 
cells. (A) Lap2α+/+ and Lap2α−/− mouse skin fibroblasts were fractionated and each fraction was subjected to 
immunoblotting. (B) Whole-cell extracts from Lap2α+/+ and Lap2α−/− mouse skin fibroblasts were subjected to 
immunoblotting. (A, B) Uncropped blot images are presented in Supplementary Fig. 5.
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The ATP-bound RFC complex binds to and opens a PCNA homotrimer ring, and the loading of the RFC-
ring-opened PCNA intermediates onto DNA triggers the release of PCNA from the RFC complex with closure 
of the PCNA ring to encircle the  DNA14,15. PCNA unloading occurs in the opposite direction. The ATP-bound 
ATAD5-RLC opens the PCNA ring, and the ATAD5-RLC-PCNA intermediates are then released from the 
 DNA19. Our results suggest that these processes occur where the related proteins are highly accumulated in the 
chromatin and/or while being tightly associated with the stationary structure because nuclease treatment and 
high salt treatment cannot extract them. Replication foci observed during the S phase could be highly enriched 
for RFC/RLC proteins. In a replication factory, many proteins, including RFC and ATAD5-RLC, participate in 
chromatin  replication13. Detection of MCM2, FEN1, and pol δ in the nuclease-resistant fractions also support 
the protein-dense cooperative replication process at specific locations in the nucleus (Fig. 1J and Supplementary 
Fig. 1). Although it is not yet known whether the replication machinery is anchored to stationary structures such 
as the nuclear matrix, a budding yeast study showing the passage of replicating DNA through the stationary 
replication factory supports our  model36. The spatial integration of replication proteins might be beneficial for 
simultaneous firing of adjacent origins and efficient replication in each replication domain.
Based on our results, the RFC and ATAD5-RLC are associated with nuclease-resistant structures regardless 
of cell cycle phase. PCNA loading and unloading occur during DNA repair synthesis in all cell cycle phases. All 
subunits of the human RFC complex and the budding yeast Elg1 rapidly increase their signals at DNA lesions, 
including DSBs, independent of cell  cycle48,49,51. It is possible that the RFC-ring-opened PCNA intermediates 
are anchored to these nuclease-resistant structures in a ‘ready-for-PCNA loading’ mode in order to rapidly load 
PCNA at any double-strand DNA/single-strand DNA junction with a 3`-hydroxyl group. This mode of PCNA 
loading might also occur during DNA replication, especially in lagging strand synthesis, which accompanies 
frequent PCNA cycling. Further studies are needed to determine whether the association of pre-formed RFC-
ring-opened PCNA intermediates with the stationary structure in itself is beneficial for PCNA loading. We 
speculate that the RFC-ring-opened PCNA intermediates are part of protein-dense aggregates maintained by 
protein–protein interactions between replication/repair proteins and their association with stationary structures, 
and this may facilitate the replication/repair process while synergizing with other proteins.
We identified LAP2 proteins as putative ATAD5 interacting proteins and confirmed interactions between 
ATAD5 and LAP2α and β (Fig. 5). RFC1 and RFC4 also interacted with LAP2α and β. Among several LAP2 
isoforms, LAP2α is distinctive in that it is the only LAP2 isoform that is present in the  nucleoplasm59. LAP2α is 
associated with the lamin A/C in the nuclear interior and regulates the mobility of lamin A/C1,9. Based on our 
new findings and other reported roles of LAP2α, we hypothesized that LAP2α could be a linker required for the 
association of the RFC/RLCs with the intra-nuclear lamin A/C. Analysis of Lap2α knockout mouse cells showed a 
clear reduction of the RFC/RLC proteins in the pellet fraction but mild reduction in the soluble fraction (Fig. 6A). 
In addition, the effect of LAP2α knockout on total protein levels of the RFC/RLC proteins was marginal except 
RFC1 and CTF18 (Fig. 6B). Considering that the soluble fractions contained four times the amount of total pro-
tein compared to the pellet fraction, these results suggest that LAP2α contributes to the association of the RFC/
RLC proteins with nuclease-resistant structures rather than contributing to the maintenance of the total protein 
levels of RFC/RLC, similar to the role of small RFC proteins. Compared to Lap2α knockout mouse fibroblast 
cells, the effect of siRNA-mediated LAP2ɑ depletion on the fractionation profile of the RFC/RLC proteins was 
marginal in HeLa cells (Supplementary Fig. 4A,B). Considering that the minimal changes were only observed 
after 6 days of transfection, it may require time for the effects of LAP2ɑ depletion to appear in HeLa cells, as 
evident in Lap2α knockout mouse cells. Another possibility is that the different degree of effect may be due to 
intrinsic differences between normal fibroblasts and cancer cells. For example, LAP2α is overexpressed in various 
human tumors and cancer cell  lines61, which may attenuate the effects of transient LAP2ɑ depletion in HeLa cells.
Based on our study, the RFC/RLC proteins are likely associated with nuclease-resistant chromatin and/or 
nuclear matrix. Extraction of the RFC/RLC proteins from the pellet fraction by adding a sonication step supports 
the chromatin association hypothesis to some extent (Fig. 1G). Protein–protein interactions between the RFC/
RLC proteins and LAP2 proteins and reduced protein levels of the RFC/RLC in pellet fractions due to LAP2α 
deficiency are consistent with NM association; however, because protein–protein interactions cannot be guar-
anteed at such high salt (2 M NaCl) wash conditions, there may be other factors at play. Our study did not show 
the degree of contribution of the two structures (chromatin and nuclear matrix) to the presence of RFC/RLC 
proteins in the pellet fraction. In addition, it is not clear whether the association of RFC/RLCs with chromatin 
and nuclear matrix occurs in the same physical place or not. Considering there is still no convincing evidence 
that a filamentous nuclear skeleton (representing the nuclear matrix) exists in living  cells62, more technically 
advanced approaches will be required to elucidate these missing parts.
It has been reported that cell proliferation was increased in Lap2α knockout  cells60,63. Considering the reduced 
protein level and association with nuclease-resistant structure of the RFC/RLC proteins by LAP2α deficiency 
(Fig. 6), the reported hyper-proliferation was different from what was expected. We speculate that multiple 
cellular functions of LAP2α generates complex outcomes. LAP2α regulates the G1 to S cell cycle transition by 
suppressing the RB/E2F  pathway63, which might explain dysregulated proliferation by LAP2α deficiency. How-
ever, how LAP2α regulates RFC/RLC proteins and the biological implications of this regulation still remains to 
be investigated.
RFC1 is essential for cell survival in eukaryotes, while the other large subunits of RLCs are not essential for 
cell viability in yeast and mammals (although some human cancer cells depend on each gene for survival)64–67. 
All small RFC subunits are essential for cell  survival65,66, and they contribute to the activity of the RFC/RLCs 
in different ways. When the RFC/RLCs bind to the PCNA clamp or the 9-1-1 checkpoint clamp, the small RFC 
proteins provide physical contacts with the  clamp68,69. The ordered hydrolysis of ATP in the RFC subunits, 
including the small RFC proteins, is required for PCNA  loading16. Here, we found that the small RFC subunits 
can also contribute to the maintenance of overall protein levels of RFC/RLCs (Fig. 4C and Supplementary Fig. 3). 
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The protein stability of the multi-subunit complex comprised of AAA + ATPase subunits is severely affected by 
deficiency of a  subunit70. Since RFC and RLCs are also AAA + ATPase complexes, the destabilization of the large 
subunits upon depletion of the small RFC subunits occurs in a similar way rather than using active degrada-
tion mechanisms, such as proteasomal degradation (Fig. 4D). It has been recently reported that many protein 
complexes are cotranslationally assembled in eukaryotes and it can prevent degradation of subunit prone to 
 aggregation71. Since the RFC interaction domain is located at C-terminal in ATAD5 and all five RFC  subunit19,68, 
rather than cotranslational subunit interaction, complex assembly right after ribosome dissociation might be 
more probable for the assembly of the RFC/RLC complex.
All large subunits of RFC and RLCs undergo phosphorylation during mitosis (Fig. 2A,B). This is consistent 
with previously published proteomics studies that showed phosphorylation of RFC1, ATAD5, and CTF18 in 
cells during G2/M  phases45,46. In this report, we showed that ATAD5 was phosphorylated at S369 by two aurora 
kinases in vitro and in the cells during mitosis (Fig. 2). Future studies should identify responsible kinases, regula-
tion, and biological significance of the mitotic phosphorylation of the large subunits of the RFC and RLCs. The 
phosphorylation of ATAD5 at S369 might be related with regulation of specific cellular processes by ATAD5 but 
not the association of ATAD5 with nuclease-resistant structures (Supplementary Fig. 2). ATAD5 localizes to the 
centrosome, the primary microtubule organizing center, where it regulates centrosome  duplication72. AURKA 
also localizes to centrosomes and is involved in centrosome separation, duplication, and maturation as well as in 
bipolar spindle  assembly73. Therefore, the relationship between ATAD5 phosphorylation at S369 and centrosome 
regulation should be investigated further. The S653 residue of ATAD5 is also reportedly phosphorylated by the 
mitotic cyclin-dependent kinase, which inhibits the interaction between ATAD5 and  BRD453,55. Our preliminary 
mass spectrometry analysis also identified another pleiotropic master mitotic kinase, Polo-like kinase 1, as an 
ATAD5-interacting protein (data not shown). These data suggest that ATAD5 is phosphorylated at multiple 
residues by different kinases during mitosis, which might regulate specific biological processes.
The most unexpected finding in our study was that neither RFC1 nor ATAD5 were detected in the soluble 
or nuclease-susceptible chromatin fractions. A previous study found that RFC1 was not present in the soluble 
fraction but was instead bound to chromatin after fractionation based on the method of Mendez and  Stillman48,74. 
However, this paper did not test whether RFC1 was eluted from the pellet (expected to contain proteins associ-
ated with chromatin or nuclear matrix) upon nuclease  treatment48. Irrespective of whether the RFC/RLCs are 
associated with the chromatin or NM, the rapid accumulation of RFC/RLC proteins at DNA damaged sites 
requires a mechanical explanation that encompasses the subcellular localization of the RFC/RLCs, even with 
the detection of RFC1 only in the nuclease-resistant fractions in our study. With the advent of new technologies, 
it will be worth investigating whether the ‘ready-for-PCNA loading’ mode by the RFC complex associated with 
the stationary structures is actually utilized during DNA replication and repair.
Methods
Cell lines, cell culture and cell synchronization. Human embryonic kidney (HEK) 293 T and HeLa 
cells were purchased from ATCC and cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum (GE Healthcare), 100 U/mL penicillin G (Life Technologies), and 100 μg/mL strep-
tomycin (Life Technologies) at 5%  CO2, 37 °C. Immortalized skin fibroblasts from Lap2α knockout mice and 
wild-type littermates were kindly provided by Dr. Foisner and were cultured as  described60. To enrich cells at the 
M phase, cells were treated with 100 ng/ml nocodazole for 12 h and collected. To obtain cells at G1 and S phases, 
cells were arrested at the M phase by the thymidine-nocodazole block (2 mM thymidine for 24 h, washing, 
incubation in fresh media for 3 h, and 100 ng/ml nocodazole for 12 h), shaken off the plate, collected, washed 
with culture medium and incubated in fresh media. To synchronize cells at the G2 phase, cells were treated with 
10 μM CDK1 inhibitor RO-3306 for 16 h.
Chemicals and antibodies. The following drugs were used in this study: Alisertib, Barasertib (Selleck-
chem), RO-3306, nocodazole, thymidine, methyl methanesulfonate, camptothecin, MG-132 (Sigma-Aldrich). 
The following antibodies were used in this study: anti-RAD17, anti-PCNA (PC10), anti-RFC4, anti-RFC5, anti-
UAF1, anti-LAMIN B1, anti-Emerin, and anti-Lamin A/C antibodies (Santa Cruz Biotechnology), anti-MCM2, 
anti-RFC2, anti-RFC3, anti-Aurora A kinase, anti-Aurora B kinase, anti-LAP2, and anti-LAP2α antibodies 
(Abcam), anti-RFC1 antibody (Novus Biologicals), anti-CDT1, anti-phospho histone H3 (ser10) antibodies 
(Cell signaling Tech), anti-phospho MCM2 (S40/41), anti-CTF18, anti-RPA2 antibodies (Bethyl Laborato-
ries), anti-DNA polymerase δ antibody (BD Biosciences), anti-histone H3 and anti-phospho H2AX antibodies 
(Thermo Fisher Scientifics), anti-FLAG, anti-HA, anti-α-tubulin antibodies (Sigma-Aldrich). The anti-human 
ATAD5 antibody was raised in rabbits using the N-terminal fragment (Residues 1–297 amino acids)54. The 
anti-human anti-pS369 ATAD5 antibody was generated in rabbits by using the pS369 synthetic ATAD5 peptide 
(AbClon Inc.).
Plasmids, small interfering RNAs (siRNAs), and transfection. LAP2α cDNA was retrieved from 
the Human HeLa QUICK-Clone cDNA (Clontech) by polymerase chain reaction. LAP2β cDNA was purchased 
from Addgene. Both cDNA was cloned into the pcDNA5/FRT/TO vector (Thermo Fisher Scientifics) together 
with HA-tag sequence in the N-terminus region. The siRNA sequences used in this study were: ATAD5 3′UTR 
(5′-GUA UAU UUC UCG AUG UAC A-3′); UAF1 (5′-AAU CAG CAC AAG CAA GAU CCA UAU A-3′); RFC4 (5′-
AAG AGA UUA GGA AGA UCU G-3′); LMNA (5′-CUU ACC GGU UCC CAC CAA A-3′); LAP2α (5′-GCA CAG 
AUU CUU AGC UCA GAU-3′); SMART pool siRNAs for AURKA, AURKB, RFC5 were used (Dharmacon). Pan 
BRD4 siRNA (siRNA ID: HSS141059) was used (Invitrogen). Transfections of plasmid DNA and small interfer-
ing RNAs (siRNAs, 20 nM), were performed using X-tremeGENE HP (Roche) and RNAiMAX (Thermo Fisher 
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Scientific) respectively, according to the manufacturer’s instructions. Transfection reagents was removed 6 h post 
transfection and fresh medium was added. Cells were analyzed at 48 h after transfection.
Subcellular fractionation. Subcellular fractionation was performed as described  in37 with slight modifica-
tion. 2.5 ×  106 HeLa cells were incubated in 150 μl CSK buffer (10 mM PIPES, 100 mM NaCl, 300 mM sucrose, 
2 mM  MgCl2, 1 mM EGTA, and 0.5% Triton X-100) for 5 min at 4 °C followed by centrifugation. Supernatant 
was collected as ‘soluble fraction’ while pellet was washed in CSK buffer and was further lysed with 35 μl CSK 
buffer supplemented with Benzonase nuclease (250 U/mL) and 5 mM  MgCl2 for 20 min at 37 °C. Then, a final 
concentration of 0.25 M ammonium sulfate was added for 5 min at 4 °C followed by centrifugation to obtain 
‘chromatin fraction’. Remaining nuclease-resistant pellet was washed with high-salt-CSK buffer (CSK buffer with 
2 M NaCl) for 5 min at 4 °C followed by centrifugation. Left-over nuclease- and high salt-resistant ‘pellet frac-
tion’ was solubilized in 40 μl Reagent 3 (Bio-Rad laboratories) containing 5 M urea and 2 M thiourea. The ratio 
of total protein extracted for each fraction was about 4:1:1 (413.0 ± 47.2, 97.2 ± 11.9 and 94.2 ± 8.8 for soluble, 
chromatin, and pellet fractions; mean ± standard deviation, μg). For immunoblotting, we used each protein frac-
tion at a ratio of 2:1:1.
Whole‑cell extracts preparation. Whole-cell extracts were prepared by cell pellet lysed with RIPA buffer 
(50 mM Tris–HCl pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.1% sodium dodecyl sulfate, 0.5% 
sodium deoxycholate) supplemented with 0.1 M phenylmethylsulfonyl fluoride, PhosSTOP Phosphatase Inhibi-
tor Cocktail (Roche), cOmplete Protease Inhibitor Cocktail (Roche) and Benzonase nuclease for 40 min on ice 
followed by sonication and centrifugation.
Immunoprecipitation and immunoblot analysis. For immunoprecipitation, cells were lysed in ice-
cold buffer X (100 mM Tris–HCl, 250 mM NaCl, 1 mM EDTA, 1% NP-40) supplemented with 0.1 M phenyl-
methylsulfonyl fluoride with PhosSTOP Phosphatase Inhibitor Cocktail (Roche), cOmplete Protease Inhibitor 
Cocktail (Roche), and Benzonase nuclease followed by sonication and centrifugation. Target proteins within 
the lysate were immunoprecipitated with indicated antibodies. For immunoblot analysis, proteins were sepa-
rated by SDS-PAGE and transferred to a nitrocellulose membrane. Membranes were incubated in Tris-buffered 
saline containing 0.1% Tween 20 supplemented with 5% skim milk powder for blocking. Membranes were then 
cut according to protein sizes and incubated with primary antibodies for overnight. After washing, the blot 
was incubated with horseradish peroxidase-conjugated secondary antibodies (Enzo Life Sciences). Signals were 
detected using enhanced chemiluminescence reagent (Thermo Fisher Scientific) and an automated imaging sys-
tem (ChemiDoc MP, Bio-Rad Laboratories). After image acquisition, antibody was stripped using the Restore 
western blot stripping buffer (Thermo Fisher Scientifics) and then reprobed with the next antibody.
Protein purification. Human ATAD5 proteins for in vitro kinase assay were purified from E. coli cells. 1 L 
culture was grown to OD of 0.6, and 1 M isopropyl β-D-1-thiogalactopyranoside (IPTG) was added for 4 h to 
express protein. E. coli cells were centrifuged and resuspended in buffer A (20 mM Tris–HCl pH 8.0, 150 mM 
NaCl, 2 mM β–mercaptoethanol) with a cOmplete Protease Inhibitor Cocktail (Roche). Cells were lysed with 
lysozyme for 1 h at 4 °C and cell lysates were cleared by ultracentrifugation (13,000 rpm, 30 min). Proteins were 
purified by sequential application of cOmplete HIS-Tag resin (Roche), and ion exchange chromatography. The 
purified AURKA, AURKB and CDK1/cyclin B1 recombinant proteins were purchased from Millipore.
The in vitro kinase assay. For the AURKA assay, 2 μg of purified ATAD5 protein was incubated with 
100 ng of AURKA in the kinase buffer (500 mM Tris–HCl pH 7.4, 5 mM  Na3VO4, 150 mM  MgCl2, 10 mM DTT, 
20 mM EGTA, 1 mM ATP) at 22 °C for 2 h. For the AURKB assay, 20.32 ng of AURKB together with 43.2 ng of 
CDK1/cyclin B1 was used at 30 °C for 2 h.
Image acquisition and image analysis. Cells plated on LabTek™ chamber slides (Thermo Fisher Sci-
entific) were treated with CSK buffer and/or Benzonase nuclease, washed with PBS, and fixed with 4% para-
formaldehyde for 20 min at room temperature. After washing, cells were mounted using ProLong Gold antifade 
reagent (Vector Laboratories, Burlingame, CA, USA). Confocal images were acquired using an LSM880 confocal 
microscope (Carl Zeiss) with a 40 × /1.2 objective lens. Image acquisition and analysis were performed with Zen 
2.6 (blue edition) (Carl Zeiss) software.
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